Member Directory

Molten Ventures (formerly Draper Esprit) invests in Europe’s tech leaders at Series A and beyond. Our companies use technology to create better ways of doing things. We focus on four sectors; Consumer technology, Digital Health & Wellness, Ai, Deeptech & Hardware, Cloud, Enterprise & Saas.

We look for high-growth companies with strong IP, powerful technology, and outstanding management teams. They operate in new markets, with serious potential for global expansion. We also look for strong margins to ensure sustainable growth, particularly for companies on a journey to profitability.

We offer investors access to private companies, in the high growth phase. Entrepreneurs come to us once they’ve initially proven their idea, and are ready to grow. We’re providing a rare opportunity to invest in companies that aspire to be attractive candidates for acquisition or IPO, with valuations from $50m to $1bn+.

Mountside Ventures was formed to optimise the fundraising process between European startups and investors. Firstly, they help the most ambitious entrepreneurs raise their Next Round of funding, with terms that are right for them, and causing the least amount of disruption to their business. Secondly, they connect the most promising Venture Fund Managers with forward-looking Limited Partners to promote the flow of venture capital into the European ecosystem.

Nyman Libson Paul are an established firm of accountants in London with over 80 years experience. Dave has structured and advised on many EIS and SEIS projects across a range of industries but has, in particular, made a significant impact in the Entertainment Industry sector, in which the firm is a significant player. Dave is a Chartered Accountant, Certified Accountant and Chartered Tax Adviser and is also Chairman of the Institute of Chartered Accountants’ Entertainment and Media Group. Dave has specialised in tax for many years, has been published in Taxation magazine as well as many other publications and has previous ‘big firm’ experience. He also ran his own promotions business for several years, which could explain his empathy for entrepreneurs!

o2h Ventures, a specialist biotech fund manager based in the heart of the thriving biotech community in Cambridge, UK. We invest in early-stage biotech companies involved in novel drug discovery, enabling service tools, and AI/ML technologies. Currently, we have two tax-efficient human health funds open for investment: the Enterprise Investment Scheme and the Seed Enterprise Investment Scheme.

To date, through our funds, we have invested over $10 million in 35+ early-stage biotech companies, empowering impactful research addressing unmet medical needs in areas such as cancer, depression, diseases of the ear and eye, psoriasis, idiopathic pulmonary fibrosis, anti-ageing, and infectious diseases. For more details, please see – www.o2hventures.com

Based in London, Oberon Group provides investment services along with strategic planning and advice to growing businesses. We deliver services to private individuals aiming to maximise returns and take advantage of diverse investment opportunities. Our specialist teams work both independently and collaboratively to deliver a dynamic and personalised service to our private and corporate clients. The business is underpinned by traditional values and integrity complemented by 21st century innovation from a proven team accomplished at delivering inspiring ideas and access to unique opportunities and networks.

At Oberon we pride ourselves in offering clients the personal attention of a private office whilst delivering the capabilities, contacts, and services of a much larger institution. Our clients value the entrepreneurial mind-set our dynamic team brings to the table where our services are tailored to a specific individual or business’ needs, and traditional approaches are considered alongside more innovative ideas. The solutions and strategies implemented are as varied as the individuals and businesses that require them.

At Obu, we’re building a critical mass of forward-thinking angel investors – both women and allies – who believe their capital, connections, wisdom and support can create a more equal, progressive, innovative start-up ecosystem.  Too many innovative, purposeful entrepreneurs are falling through the cracks in a manmade system. We need change. And to level the playing field for women entrepreneurs, we need to provide more women and ally investors with a practical platform to invest in them. So that’s what we do at Obu.

Octopus is synonymous with small company investing and is the UK’s largest specialist manager of tax efficient investments, managing more than £13bn on behalf of both retail and institutional investors. Our experience spans more than 20 years and, in that time, we have invested over £2 billion in early-stage companies.

Each Octopus Ventures EIS portfolio will have around 10-15 companies selected for their ambitious growth targets and potential to become a household name of the future. Investors will have access to the expertise of Octopus Ventures, one of the largest venture capital teams in Europe. Our previous track record for identifying, growing and exiting some of Britain’s brightest companies includes investments in Graze, Secret Escapes, Zoopla and Tails.com, to name but a few. Our pipeline of opportunities spans very early stage (seed) through to Series A and Series B investments.

We have aligned our fees with the interests of our investors. Our annual management charge is only payable if a company is sold for more than the amount invested into it.

We invest in seed and early stage companies from a range of different industries, with a particular focus on technology. Oxford Capital is one of the most experienced tax-efficient investment managers in the UK. Since pioneering the first EIS funds in 1999, Oxford Capital has been recognised multiple times as Best EIS Fund Manager. We have invested over £400m in small companies across the UK and are proud of partnering with some exceptional founders. Our current portfolio includes some well known brands such as Curve, Moneybox, Push Doctor, Spoke and more.  More information can be found at www.oxcp.com.

Oxford Innovation Finance is the home of the Oxford Innovation EIS and SEIS Growth Funds and OION, one of the oldest and largest Angel Investment Networks in the UK. Providing investors with the opportunity to invest in pre-screened opportunities either directly through our Angel Network or indirectly via our Growth Funds, and providing companies with the opportunity to secure investment from a large, diverse investor base. Our Growth Funds and OION Angel Investors invest in the next generation of innovative, high-growth technology and science businesses from across the UK, creating a diversified portfolio across sectors. There is a focus on using the wider Oxford Innovation network and Angel Investors with industry experience to support the portfolio companies. Oxford Innovation has over thirty-five years’ experience of incubating and accelerating high growth businesses through Oxford Innovation Space, operators of a network of innovation centres across large parts of the UK, and through Oxford Innovation Advice, who provide a range of coaching support for innovative businesses.

Par Equity is an Edinburgh-based venture capital boutique active across the United Kingdom. It invests in innovative small companies with high growth potential within a number of carefully selected sub-sectors, including software, medical devices, energy-efficient lighting and technical textiles. Although portfolio companies do include businesses serving consumer markets, Par Equity is particularly interested in business-to-business propositions. Investors include many individuals with directly relevant experience of the sub-sectors Par Equity invests in, providing a reserve of intellectual capital to be deployed alongside financial capital. Par Equity offers execution-only investment services to business angels as well as managing an evergreen EIS fund (the Par Syndicate EIS Fund) that invests alongside and on the same terms as business angels in SEIS and EIS-qualifying companies.